More on Enanta Pharma fiscal Q3 results

|About: Enanta Pharmaceuticals... (ENTA)|By:, SA News Editor

Enanta Pharmaceuticals (NASDAQ:ENTA) fiscal Q3 results: Revenues: $42.1M (+999%); Operating Expenses: $7.2M (+22.8%); Operating Income: $34.9M (+935.2%); Net Income: ($50.1M) (+999%); EPS: ($2.61) (+999%); Quick Assets: $95.9M (-5.5%).

No financial guidance given.